A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

Weeds in soybean fields are doing more than competing for resources like nutrients and water. More than 100 common weed species are hosts, creating refuge for soybean cyst nematode populations and ...

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

Researchers at National Taiwan University refined a pseudo-germ-free mouse model to make gut microbiome studies safer for mice and more reliable. Using this model, they found that antibiotic-driven ...

Background A resemblance of pancreatic tumours to their native tissue architecture remains largely unexplored, while it may ...

The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified ...

A new drug for pancreatic cancer is showing promise in early testing. Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical ...

The mega-threat of the microscopic soybean cyst nematode (SCN) looms large over U.S. soybean fields. SCN’s insatiable appetite for soybean roots makes it the No. 1 yield-reducing soybean pest ...

Researchers have demonstrated a promising new approach to stopping pancreatic cancer before it starts, using experimental drugs to eliminate microscopic precancerous lesions in the pancreas.

Chronic pancreatitis is an inflammatory disease and is difficult to manage despite advancements in medical science.

Sisters with family history among first to test new screening technology designed to detect abnormalities before cancer ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...